3 MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3 KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER

摘要

The present invention relates to a method and composition for treating a hyperproliferative disorder in a patient using the PI3K inhibitor GDC-0032 as a single agent or in combination with a chemotherapeutic agent.